drugset / Trial / NCT01340157

Fexinidazole (1200mg) Bioavailability Under Different Food Intake Conditions

NCT01340157

Phase 1 Completed 12 enrolled Drugs for Neglected Diseases Sanofi · collab
RandomizedCrossoverOpen-labelBasic science

Summary

The present study is designed to assess the impact of concomitant food intake on the relative bioavailability of a single oral fexinidazole tablet administration.

Timeline

Start
2011-02
Primary completion
2011-04
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Fexinidazole Small molecule 1200 mg Oral

Indications

No indication recorded.